Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD)

Romina Mastronicola, Maëlys Bresson, Giacomo Gravante, Sophie Cortese, Emilie Beulque, Fadila Chergui, Alexandre Harlé, Gilles Dolivet

Open source

DOI
10.2196/89973
Published
2026-11-05
Container
JMIR Research Protocols
Publisher
JMIR Publications Inc.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2196/89973,
  title = {Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD)},
  author = {Romina Mastronicola and Maëlys Bresson and Giacomo Gravante and Sophie Cortese and Emilie Beulque and Fadila Chergui and Alexandre Harlé and Gilles Dolivet},
  year = {2026},
  journal = {JMIR Research Protocols},
  doi = {10.2196/89973},
  url = {https://doi.org/10.2196/89973}
}

RIS

TY  - JOUR
TI  - Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD)
AU  - Romina Mastronicola
AU  - Maëlys Bresson
AU  - Giacomo Gravante
AU  - Sophie Cortese
AU  - Emilie Beulque
AU  - Fadila Chergui
AU  - Alexandre Harlé
AU  - Gilles Dolivet
PY  - 2026
JO  - JMIR Research Protocols
DO  - 10.2196/89973
UR  - https://doi.org/10.2196/89973
ER  - 

APA

Mastronicola, R., Bresson, M., Gravante, G., Cortese, S., Beulque, E., Chergui, F., Harlé, A., & Dolivet, G. (2026). Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD). JMIR Research Protocols. https://doi.org/10.2196/89973

Source records